(Q44532768)

English

Effect of fasting glucose levels on mortality rate in patients with and without diabetes mellitus and coronary artery disease undergoing percutaneous coronary intervention

scientific article published in August 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Effect of fasting glucose levels on mortality rate in patients with and without diabetes mellitus and coronary artery disease undergoing percutaneous coronary intervention (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

1 reference

based on heuristic

inferred from title

coronary artery disease

1 reference

based on heuristic

inferred from title

author name string

Joseph B Muhlestein

1

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Jeffrey L Anderson

2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Benjamin D Horne

3

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Farangis Lavasani

4

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Chloe A Allen Maycock

5

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Tami L Bair

6

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Robert R Pearson

7

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

John F Carlquist

8

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Intermountain Heart Collaborative Study Group

9

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

language of work or name

0 references

publication date

1 August 2003

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

American Heart Journal

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

146

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

351-358

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Diabetes and cardiovascular disease. The Framingham study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900235-7

7 January 2021

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900235-7

7 January 2021

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900235-7

7 January 2021

Long-term clinical outcome in the Bypass Angioplasty Revascularization Investigation Registry: comparison with the randomized trial. BARI Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900235-7

7 January 2021

Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically demonstrated coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900235-7

7 January 2021

Is borderline fasting hyperglycemia a risk factor for cardiovascular death?

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900235-7

7 January 2021

Dysglycaemia and risk of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900235-7

7 January 2021

The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900235-7

7 January 2021

Is glucose a continuous risk factor for cardiovascular mortality?

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900235-7

7 January 2021

Impaired fasting glucose concentrations in nondiabetic patients with ischemic heart disease: a marker for a worse prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900235-7

7 January 2021

Diabetes mellitus and macrovascular complications. An epidemiological perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900235-7

7 January 2021

Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900235-7

7 January 2021

High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900235-7

7 January 2021

Clinical impact of borderline and undiagnosed diabetes mellitus in patients with coronary artery disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900235-7

7 January 2021

Implementation of a computerized cardiovascular information system in a private hospital setting.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900235-7

7 January 2021

Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900235-7

7 January 2021

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900235-7

7 January 2021

Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900235-7

7 January 2021

Prevention Conference VI: Diabetes and Cardiovascular Disease: executive summary: conference proceeding for healthcare professionals from a special writing group of the American Heart Association

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900235-7

7 January 2021

Oxidative stress and diabetic vascular complications

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900235-7

7 January 2021

Body mass index, diabetes, and C-reactive protein among U.S. adults

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900235-7

7 January 2021

Lipoprotein glycation and its metabolic consequences

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900235-7

7 January 2021

Lilly Lecture 1993. Glycation and diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900235-7

7 January 2021

Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes?

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900235-7

7 January 2021

Obesity, metabolic syndrome, and coronary atherosclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900235-7

7 January 2021

Epidemiology of insulin resistance and its relation to coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900235-7

7 January 2021

Is insulin really a heart disease risk factor

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900235-7

7 January 2021

Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900235-7

7 January 2021

Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900235-7

7 January 2021

Antidiabetic drugs present and future: will improving insulin resistance benefit cardiovascular risk in type 2 diabetes mellitus?

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900235-7

7 January 2021

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900235-7

7 January 2021

Identifiers

10.1016/S0002-8703(03)00235-7

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44532768&oldid=2027026654"